Search the Newsreel

Verisk Analytics Inc. stock underperforms Wednesday when compared to competitors

Shares of Verisk Analytics Inc. (VRSK) dropped 2.10% on Wednesday, closing at $188.75. This decline occurred during a mixed trading session where the Dow Jones Industrial Average rose, but the S&P 500 Index fell. This marks the stock's fifth consecutive day of losses.

Qualys (QLYS) Soars As Earnings Beat And AI Security Push Ignite Rally

Qualys (QLYS) shares rallied 15.8% after reporting strong Q2 earnings, beating analyst expectations on both revenue and EPS, and raising its full-year guidance. The company's push into AI security with new tools like InstaScan and broader TotalAI capabilities, coupled with its robust financial performance, …

Verisk (VRSK) CIO Change Hands CTO Interim Role After Nick Daffan Steps Down

Verisk Analytics (VRSK) announced that EVP and CIO Nick Daffan is stepping down after two decades, with the company's CTO assuming interim CIO responsibilities. This leadership change occurs as Verisk focuses heavily on AI, cloud infrastructure, and advanced analytics, amidst strong Q2 2026 results …

CLST's Q2 Earnings Flat Y/Y, Merger Costs and Loan Weakness Hurt

Catalyst Bancorp, Inc. (CLST) reported flat Q2 2026 earnings per share year-over-year, impacted by higher operating costs including merger-related expenses, despite a rise in net interest income. The company saw an increase in total assets and deposits, but net loans receivable declined, though credit …

Qualys stock hits 52-week high at $200.57

Qualys (QLYS) stock reached a new 52-week high of $200.57, reflecting strong market confidence and growth in the cybersecurity sector. Despite being considered overvalued by InvestingPro analysis, the company reported better-than-expected Q2 revenue and profit, leading to a raised full-year outlook. This performance highlights …

Health Catalyst (HCAT) Q2 Earnings Report Preview: What To Look For

Health Catalyst (HCAT) is set to report its Q2 earnings, with analysts expecting a 14.6% year-on-year revenue decline. The company beat revenue expectations last quarter but issued slower guidance. While the data and analytics software segment has shown positive investor sentiment, Health Catalyst's stock …

Is Verisk Analytics (VRSK) an Undervalued Data Monopoly in Insurance?

Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its "Mid Cap Strategy". A copy of the Q2 2026 investor letter can be downloaded here. In the quarter, equity markets posted strong returns as resilient economic growth …

Qualys CEO and CFO to join live webcast from Boston on Aug. 11

Qualys (NASDAQ: QLYS) announced that President and CEO Sumedh Thakar and CFO Joo Mi Kim will participate in Canaccord Genuity's 46th Annual Growth Conference on Tuesday, August 11, 2026, in Boston. They will host a fireside chat at 10:00 a.m. ET, with a live …

Qualys to Speak at Upcoming Investor Conference

Qualys, Inc. announced that its management, including President and CEO Sumedh Thakar and CFO Joo Mi Kim, will participate in Canaccord Genuity's 46th Annual Growth Conference. They will host one-on-one meetings and a fireside chat on August 11, 2026, which will also be webcast …

Qualys Earnings, Revenue Top Estimates. Cybersecurity Stock Climbs.

Qualys stock delivers 68% return after InvestingPro Fair Value signal By Investing.com

InvestingPro's Fair Value models identified Qualys (NASDAQ: QLYS) as significantly undervalued in March 2026, leading to a 67.74% return for investors who acted on the signal. The cybersecurity stock, initially trading at $92.34, reached $161.06, demonstrating the effectiveness of intrinsic value analysis. This success …

Mineralys Therapeutics (MLYS) Heads Into Earnings As Lorundrostat Hopes Meet Undervalued View

Mineralys Therapeutics (MLYS) is set to report its Q2 2026 earnings on August 11, 2026, with its stock currently seen as 47.9% undervalued by analysts, suggesting a fair value of $50.88 compared to its recent close of $26.50. This valuation hinges on the potential …

The Manufacturers Life Insurance Company Sells 98,653 Shares of Annaly Capital Management Inc $NLY

The Manufacturers Life Insurance Company reduced its stake in Annaly Capital Management Inc. by 20.1% in the first quarter, selling 98,653 shares and retaining 392,128 shares valued at approximately $8.3 million. Despite this, institutional investors collectively own 51.56% of the company, and analysts generally …

Qualys drives up current billings 16% as it gains market share: analysts

Qualys reported a 16% year-over-year increase in current billings to $176.5M in its second quarter, marking its strongest growth in nearly three years. This surge, attributed to larger upsells and new product activity, has garnered positive feedback from financial analysts. The company's recent product …

Qualys, Inc. Stock 12‑Month Price Target Raised to $171.94, Implies 7% Upside

Analysts have raised the 12-month price target for Qualys, Inc. (QLYS) stock to an average of $171.94, up from $135.38, with a range of $125 to $220. This new target implies a potential upside of approximately 7% based on the August 4th closing price. …

Qualys (QLYS) Could Be 41% Overvalued Following Its Raised 2026 Guidance

Qualys (NASDAQ:QLYS) Hits New 12-Month High Following Strong Earnings

Qualys (QLYS) Stock Jumps 14% After Hours: Here's Why Qualys Shares Jump 14% After Hours on Strong Q2 Res

Qualys (QLYS) shares surged 14% in after-hours trading after reporting strong second-quarter results that surpassed analyst estimates. The company exceeded revenue forecasts, achieved a 46% adjusted EBITDA margin, and raised its full-year 2026 revenue and EPS guidance. Qualys also launched InstaScan, an AI-driven vulnerability …

Qualys Inc (QLYS) (Q2 2026) Earnings Call Highlights: AI-Driven Innovation and Raised Guidance ...

This article first appeared on GuruFocus. Revenue: $182.2 million, up 11% year-over-year. Adjusted EBITDA: $83.8 million, representing a 46% margin, up from 45% last year. EPS: $1.98 per diluted share for Q2 2026. Free Cash Flow: $55.9 million, representing a 31% margin. Operating Expenses: …

Joo Mi Kim Sells 1,627 Shares of Qualys (NASDAQ:QLYS) Stock

Qualys CFO Joo Mi Kim sold 1,627 shares of QLYS stock for approximately $249,000 as part of a pre-arranged trading plan, reducing her direct holdings to 75,743 shares. This transaction follows other recent sales by Kim, even as Qualys exceeded Q2 earnings and revenue …

Annaly (NYSE: NLY) CEO sells 50,000 shares in 10b5-1 trade

Annaly Capital Management CEO and Co-CIO David L. Finkelstein sold 50,000 shares of common stock on August 3, 2026, at a weighted average price of $22.89 per share. This sale was conducted under a Rule 10b5-1 plan established in November 2025 for tax and …

Health Catalyst, Inc. expected to post earnings of 3 cents a share - Earnings Preview

Health Catalyst, Inc. (HCAT) is projected to report earnings of 3 cents per share. This earnings preview, sourced from Refinitiv via Reuters, indicates the anticipated financial performance for the company. The full article provides further details on these expectations.

Qualys (NASDAQ:QLYS) Beats Q2 CY2026 Sales Expectations, Stock Soars

Qualys pops as Q2 results, guidance top estimates (QLYS:NASDAQ)

Qualys (QLYS) shares increased by 6.2% in extended trading after the cybersecurity firm announced second-quarter results and guidance that surpassed Wall Street's expectations. The company reported adjusted earnings of $1.98 per share for the period ending June 30. Revenue also saw a rise during …

Earnings Flash (QLYS) Qualys, Inc. Posts Q2 Adjusted EPS $1.98 per Share, vs. FactSet Est of $1.78

Qualys, Inc. (QLYS) reported Q2 adjusted EPS of $1.98 per share, surpassing FactSet's estimate of $1.78. The company also announced an increase in its Q2 revenue to $182.2 million, exceeding the FactSet estimate of $178.6 million. Following these results, Qualys, Inc. raised its earnings …

Qualys, Inc. (NASDAQ: QLYS) lifts 2026 guidance after 11% Q2 growth

Qualys Announces Second Quarter 2026 Financial Results

Q2 Revenue Growth of 11% Year-Over-Year Raises 2026 Revenue Guidance to $732.0-$738.0 million FOSTER CITY, Calif., Aug. 4, 2026 /PRNewswire/ -- Qualys, Inc. (NASDAQ: QLYS), a leading provider of disruptive cloud-based IT, security and compliance solutions, today announced financial results for the second quarter …

All eyes on Qualys earnings amid vulnerability management surge

Qualys Inc. is set to report second-quarter earnings, with investors keen to see if the rise in vulnerability disclosures translates into revenue growth and progress in its platform transition. Analysts anticipate $1.78 EPS on $178.63 million revenue, despite a neutral consensus rating and concerns …

Verisk Analytics Stock (VRSK) Opinions on Earnings and Acquisitions

This article discusses Verisk Analytics (VRSK) stock, focusing on social media opinions regarding its recent Q1 2026 earnings, which showed modest revenue and EPS growth, and its acquisition of McKenzie Intelligence Solutions. It also provides detailed breakdowns of insider trading activity, congressional stock trades, …

Why (CLST) Price Action Is Critical for Tactical Trading

This article provides an analysis of Catalyst Bancorp Inc. (NASDAQ: CLST) for tactical trading, highlighting a weak near-term sentiment but strong long-term outlook. It details specific trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with entry zones, targets, and stop losses. The analysis also includes …

Mineralys schedules live webcast for Aug. 11 Q2 update

Mineralys Therapeutics (Nasdaq: MLYS) announced it will report its second-quarter 2026 financial results after market close on Tuesday, August 11, 2026. The company will host a conference call and live webcast for investors and analysts at 4:30 p.m. ET on the same day to …

nCino, Braze, ServiceNow, Health Catalyst, and Palo Alto Networks Shares Are Soaring, What You Need To Know

Shares of nCino, Braze, ServiceNow, Health Catalyst, and Palo Alto Networks surged following easing geopolitical tensions and a new wave of AI-driven M&A activity. A diplomatic resolution regarding the Strait of Hormuz led to a drop in Treasury yields, benefiting growth-oriented tech equities. The …

Mineralys Therapeutics to Announce Second Quarter 2026

Mineralys Therapeutics, Inc. announced it will report its financial results for the second quarter ended June 30, 2026, after the financial markets close on Tuesday, August 11, 2026. The company will host a conference call on the same day at 4:30 p.m. ET to …

Qualys (NASDAQ:QLYS) Issues Q3 2026 Earnings Guidance

Mineralys Therapeutics (MLYS) to Release Quarterly Earnings on Tuesday

Qualys, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:QLYS) 2026-08-04

Qualys, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Management attributes …